Dayvigo Side Effects and Weight Gain: Trial Incidence Rates
Weight gain wasn't a distinct adverse event in Dayvigo trials; somnolence was most common, at 10% (5mg) to 22% (10mg). See full incidence data by dose.
V2 Lemborexant: Side Effects
5 source-based articles maintained by the HealthRX.com Editorial Team.
5articles
2topic areas covered
Jul 14, 2025latest review
V2 Lemborexant: Side Effects library
Showing 5 of 5 clinical reviews.
Dayvigo Side Effects Severity Distribution by Patient Phenotype
A clinical breakdown of lemborexant (Dayvigo) adverse events by severity grade and patient subgroup, drawing on key trial data, FDA labeling, and FAERS post-market reports.
Dayvigo Side Effects: Delayed-Onset Side Effects You Should Know
A guide to delayed-onset side effects of Dayvigo (lemborexant), including next-day somnolence, sleep paralysis, complex sleep behaviors, and long-term safety data from key trials and FAERS.
Dayvigo Side Effects: Potentially Permanent Adverse Events Explained
A detailed clinical review of Dayvigo (lemborexant) side effects, including rare, serious, and potentially long-lasting adverse events drawn from key trials, FDA labeling, and post-market surveillance data.
Lemborexant Euphoria and Laughter: Case Report Findings
Case reports link lemborexant to euphoria and laughter alongside rarer risks like complex sleep behaviors and hallucinations. See what the evidence shows.